Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
GPMT test already available (conducted in 1991)
Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Harlan Olac Ltd. (Bicester, Oxfordshire, England)
- Age at study initiation: ca. 4 weeks
- Weight at study initiation: 224-265 g
- Housing: groups of 5 in stainless steel cages
- Diet (e.g. ad libitum): ad libitum (certified diet)
- Water (e.g. ad libitum): ad libitum (analyzed by local water authiorities)
- Acclimation period: 11 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18°C (15-23 °C)
- Humidity (%): 55% (40-70%)
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 h
Route:
intradermal and epicutaneous
Vehicle:
paraffin oil
Concentration / amount:
Induction:
Intradermal: 0.1 ml 30 % v/v RAPI Cure CHVE in paraffin oil
Dermal: 10 % Sodium lauryl sulphate on day 7 to make the skin more susceptible and 100 % Rapi-cure on day 8

Challenge: 100 % and 30 % v/v RAPI Cure CHVE in paraffin oil
Route:
epicutaneous, occlusive
Vehicle:
paraffin oil
Concentration / amount:
Induction:
Intradermal: 0.1 ml 30 % v/v RAPI Cure CHVE in paraffin oil
Dermal: 10 % Sodium lauryl sulphate on day 7 to make the skin more susceptible and 100 % Rapi-cure on day 8

Challenge: 100 % and 30 % v/v RAPI Cure CHVE in paraffin oil
No. of animals per dose:
20
Details on study design:
RANGE FINDING TESTS:
intra dermal
50, 30, 10, 5, 3 % Rapi-cure CHVE in Paraffin oil and
50, 30, 10, 5, 1 % Rapi-cure CHVE in paraffin oil + FCA
dermal
100 , 50, 30, 10 % Rapi-cure CHVE in Paraffin oil

MAIN STUDY
- Test groups: 20 animals
- Control group: 20 animals

A. INDUCTION EXPOSURE
Intradermal: 0.1 ml 30 % v/v RAPI Cure CHVE in paraffin oil + FCA
Dermal : 10 % Sodium lauryl sulphate on day 7 to make the skin more susceptible and 100 % Rapi-cure on day 8

B. CHALLENGE EXPOSURE
- Exposure period: 24 h 8 (occlusive)
- Site: flank
- Concentrations: 100 % an 30 % v/v in paraffin oil
- Evaluation (hr after challenge): 24 and 48 h
Positive control substance(s):
not specified
Positive control results:
It is not reported whether there are regular experiments with a positive control substance conducted in the testing facility to test the guinea pig strain for positive response and the study personal to be able to identify a positive response. Due to animal welfare there is usually no positive control for each experiment.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
30%
No. with + reactions:
19
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 30%. No with. + reactions: 19.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
30%
No. with + reactions:
10
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 30%. No with. + reactions: 10.0. Total no. in groups: 20.0.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
30%
No. with + reactions:
10
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 30%. No with. + reactions: 10.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
30%
No. with + reactions:
7
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 30%. No with. + reactions: 7.0. Total no. in groups: 20.0.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
30%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 30%. No with. + reactions: 0.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
30%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 30%. No with. + reactions: 0.0. Total no. in groups: 20.0.
Interpretation of results:
sensitising
Remarks:
Migrated information
Executive summary:

A Maggnusson & Kligman Maximization test was conducted accoording to GLP-requirements and OECD Guideline No. 406. 10 of 20 Dunking Hartley guinea pigs developed a contact dermatitis against 30 % RAPI-cure CHVE in paraffin oil in that test.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

A Maggnusson & Kligman Maximization test was conducted accoording to GLP-requirements and OECD Guideline No. 406. 10 of 20 Dunking Hartley guinea pigs developed a contact dermatitis against 30 % 1,4-bis[(vinyloxy)methyl]cyclohexane in paraffin oil.


Migrated from Short description of key information:
Maggnusson & Kligman Maximization test (OECD Guideline No. 406): sensitising

Justification for selection of skin sensitisation endpoint:
Only one study available

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available
Additional information:
Migrated from Short description of key information:
No case reports known.

Justification for classification or non-classification

Classification for sensitisation (cat. 1) is warranted according to the criteria of EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.